Keywords: Pfizer, Myeloid leukemia, Mylotarg, FDA, Withdrawn in USA

Pfizer withdraws leukemia drug Mylotarg from US Market on safety concerns and poor efficacy

Article | 22 June 2010

Print This

At the request of the US Food and Drug Administration, global drug behemoth Pfizer said that it is voluntarily withdrawing ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in